Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Sep. 04, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock, shares authorized 250,000,000   250,000,000  
Common stock, shares, issued 188,052,593   150,118,024  
Common stock, shares, outstanding 188,052,593   150,118,024  
Proceeds from warrant exercises $ 101,036,839 $ 1,690,604    
Unvested options 0      
Unrecognized equity-based compensation expense $ 0      
2021 Equity Incentive Plan [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Share based compensation arrangement 3,267,040     9,000,000
Common Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock, shares authorized 250,000,000      
Common stock, shares, issued 188,052,593   150,118,024  
Common stock, shares, outstanding 188,052,593   150,118,024  
Issuance of common stock upon exercise of warrants, shares 36,934,569 880,798    
Warrant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Issuance of common stock upon exercise of warrants, shares 36,894,569      
Proceeds from warrant exercises $ 111,029,493